Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose

August 22, 2025 updated by: Mount Saint Vincent University

Sensory, Satiating and Glycaemic Characteristics of Cheese and Non-dairy Alternative Products to Cheese

The project will consist of two studies. One study will explore the satiating properties of dairy cheese and its dairy-free substitute when consumed ad libidum, and another study will investigate their effects on postprandial glycemia. Both studies will involve healthy young adults. The secondary outcomes of these studies will be food sensory characteristics, diet-induced thermogenesis, subjective feeling of fatigue and energy, gastrointestinal comfort level, and food intake. The proposed project results will help to better understand the health properties of the cheese and its dairy-free substitute.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3M 2J6
        • Recruiting
        • Mount Saint Vincent University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Young healthy adults

Exclusion Criteria:

  • Breakfast skipper
  • Smoker (including e-cigarettes) / cannabis consumer
  • Be underweight, overweight or obese
  • Have chronic diseases, including diabetes
  • Taking certain medication
  • Have lactose intolerance, food allergies or gastrointestinal disorders (e.g., irritable bowel syndrome, or others).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dairy
A food containing dairy cheese
Food
Experimental: Non-Dairy
A food containing vegan alternative to cheese
Food
Experimental: Conrtol
A control treatment in the form of food
Food

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satiety
Time Frame: 0-120 minutes
The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.
0-120 minutes
Blood glucose
Time Frame: 0-120 minutes
The concentrations of blood glucose
0-120 minutes
Insulin
Time Frame: 0-120 minutes
The concentrations of insulin
0-120 minutes
Food intake
Time Frame: 0 minutes, 120 minutes
Energy intake with an ad libitum meal at 120 minutes
0 minutes, 120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy and Fatigue
Time Frame: 0-120 minutes
Subjective perception of feeling energetic and fatigue
0-120 minutes
Gastrointestinal comfort
Time Frame: 0-120 minutes
The subjective feeling of wellness and gastrointestinal discomfort parameters including the feeling of nausea, stomach cramps, flatulency, diarrhea and a subjective feeling of wellness, each measured with 100mm visual analogue scales.
0-120 minutes
Diet-induced thermogenesis
Time Frame: 0-120 minutes
Indirect calorimetry
0-120 minutes
Sensory characteristics
Time Frame: 0 minutes, 120 minutes
The perception of pleasantness of the treatments (0 minutes) and a test meal (at 120 minutes) will be measured with 9-point hedonic and 100mm visual analogue scales.
0 minutes, 120 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 4, 2024

Primary Completion (Estimated)

August 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

August 1, 2024

First Submitted That Met QC Criteria

August 20, 2024

First Posted (Actual)

August 23, 2024

Study Record Updates

Last Update Posted (Estimated)

August 29, 2025

Last Update Submitted That Met QC Criteria

August 22, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-147

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose

Clinical Trials on Food

Subscribe